Most not too long ago, it has been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in very similar areas as classical opioid receptors, it binds to a wide array of endogenous opioids. Not like most opioid receptors, this receptor https://emilyw096qss6.ourabilitywiki.com/user